Radiofrequency ablation of hepatocellular carcinoma guided by real-time physics-based ablation simulation: a prospective study

References

• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):1–9. doi: 10.1148/radiol.14132958.
   PubMed Web of Science ®Google Scholar
• Singal AG, Llovet JM, Yarchoan M, et al. AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922–1965. doi: 10.1097/HEP.0000000000000466.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. Am J Roentgenol. 2007;188(2):480–488. doi: 10.2214/AJR.05.2079.
   PubMed Web of Science ®Google Scholar
• Kim YS, Lee WJ, Rhim H, et al. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. Am J Roentgenol. 2010;195(3):758–765. doi: 10.2214/AJR.09.2954.
   PubMed Web of Science ®Google Scholar
• Jiang C, Liu B, Chen S, et al. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging. Int J Hyperthermia. 2018;34(8):1135–1141. doi: 10.1080/02656736.2017.1411981.
   PubMed Web of Science ®Google Scholar
• Doyle A, Gorgen A, Muaddi H, et al. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients. J Hepatol. 2019;70(5):866–873. doi: 10.1016/j.jhep.2018.12.027.
   PubMed Web of Science ®Google Scholar
• Solbiati M, Muglia R, Goldberg SN, et al. A novel software platform for volumetric assessment of ablation completeness. Int J Hyperthermia. 2019;36(1):337–343.
   PubMed Web of Science ®Google Scholar
• Shin S, Lee JM, Kim KW, et al. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma. Am J Roentgenol. 2014;203(1):70–77. doi: 10.2214/AJR.13.11709.
   PubMed Web of Science ®Google Scholar
• Habibollahi P, Sheth RA, Cressman ENK. Histological correlation for radiofrequency and microwave ablation in the local control of hepatocellular carcinoma (HCC) before liver transplantation: a comprehensive review. Cancers (Basel). 2020;13(1):104. doi: 10.3390/cancers13010104.
   PubMed Web of Science ®Google Scholar
• Okusaka T, Okada S, Ueno H, et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer. 2002;95(9):1931–1937. doi: 10.1002/cncr.10892.
   PubMed Web of Science ®Google Scholar
• Liao M, Zhong X, Zhang J, et al. Radiofrequency ablation using a 10-mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: a prospective randomized trial. J Surg Oncol. 2017;115(8):971–979. doi: 10.1002/jso.24607.
   PubMed Web of Science ®Google Scholar
• Laimer G, Schullian P, Jaschke N, et al. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol. 2020;30(5):2463–2472. doi: 10.1007/s00330-019-06609-7.
   PubMed Web of Science ®Google Scholar
• Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252(6):903–912. doi: 10.1097/SLA.0b013e3181efc656.
   PubMed Web of Science ®Google Scholar
• Widmann G, Schullian P, Haidu M, et al. Targeting accuracy of CT-guided stereotaxy for radiofrequency ablation of liver tumours. Minim Invasive Ther Allied Technol. 2011;20(4):218–225. doi: 10.3109/13645706.2010.533923.
   PubMed Web of Science ®Google Scholar
• Pereira PL, Trübenbach J, Schenk M, et al. Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology. 2004;232(2):482–490. doi: 10.1148/radiol.2322030184.
   PubMed Web of Science ®Google Scholar
• Sakakibara M, Ohkawa K, Katayama K, et al. Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy. Am J Roentgenol. 2014;202(5):W487–95. doi: 10.2214/AJR.13.11384.
   PubMed Web of Science ®Google Scholar
• Laimer G, Schullian P, Putzer D, et al. Can accurate evaluation of the treatment success after radiofrequency ablation of liver tumors be achieved by visual inspection alone? Results of a blinded assessment with 38 interventional oncologists. Int J Hyperthermia. 2020;37(1):1362–1367. doi: 10.1080/02656736.2020.1857445.
   PubMed Web of Science ®Google Scholar
• Joo I, Morrow KW, Raman SS, et al. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control. Eur Radiol. 2022;32(9):6327–6335. doi: 10.1007/s00330-022-08723-5.
   PubMed Web of Science ®Google Scholar
• Safi W, Rauscher I, Umgelter A. Contrast-induced acute kidney injury in cirrhotic patients. A retrospective analysis. Ann Hepatol. 2015;14(6):895–901. doi: 10.5604/16652681.1171779.
   PubMed Web of Science ®Google Scholar
• Zhou C, Wang R, Ding Y, et al. Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma. Int J Clin Exp Pathol. 2014;7(5):2579–2586.
   PubMed Web of Science ®Google Scholar
• Chang IA, Nguyen UD. Thermal modeling of lesion growth with radiofrequency ablation devices. Biomed Eng Online. 2004;3(1):27. doi: 10.1186/1475-925X-3-27.
   PubMedGoogle Scholar
• Duan B, Wen R, Fu Y, et al. Probabilistic finite element method for large tumor radiofrequency ablation simulation and planning. Med Eng Phys. 2016;38(11):1360–1368. doi: 10.1016/j.medengphy.2016.08.007.
   PubMed Web of Science ®Google Scholar
• Borsic A, Hoffer E, Attardo EA. GPU-Accelerated real time simulation of radio frequency ablation thermal dose. In: 2014 40th Annual Northeast Bioengineering Conference (NEBEC) [Internet]. Boston, MA, USA: IEEE; 2014. p. 1–2. Available from: http://ieeexplore.ieee.org/document/6972736/. doi: 10.1109/NEBEC.2014.6972736.
   Google Scholar
• Hoffer EK, Borsic A, Patel SD. Validation of software for patient-specific real-time simulation of hepatic radiofrequency ablation. Acad Radiol. 2022;29(10):e219–e227. doi: 10.1016/j.acra.2021.12.018.
   PubMed Web of Science ®Google Scholar
• Moche M, Busse H, Futterer JJ, et al. Clinical evaluation of in silico planning and real-time simulation of hepatic radiofrequency ablation (ClinicIMPPACT trial). Eur Radiol. 2020;30(2):934–942. doi: 10.1007/s00330-019-06411-5.
   PubMed Web of Science ®Google Scholar
• Audigier C, Mansi T, Delingette H, et al. Efficient lattice Boltzmann solver for patient-specific radiofrequency ablation of hepatic tumors. IEEE Trans Med Imaging. 2015;34(7):1576–1589. doi: 10.1109/TMI.2015.2406575.
   PubMed Web of Science ®Google Scholar
• American College of Radiology Committee on LI-RADS®. CT/MRI LI-RADS (R) v2018 Core [Internet]. American College of Radiology; [cited 2023 Aug 1]. Available from: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS.
   Google Scholar
• Widmann G, Schullian P, Haidu M, et al. Respiratory motion control for stereotactic and robotic liver interventions. Int J Med Robot. 2010;6(3):343–349. doi: 10.1002/rcs.343.
   PubMed Web of Science ®Google Scholar
• Klein S, Staring M, Murphy K, et al. Elastix: a toolbox for intensity based medical image registration. IEEE Trans Med Imaging. 2010;29(1):196–205. doi: 10.1109/TMI.2009.2035616.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Lencioni R. mRECIST for HCC: performance and novel refinements. J Hepatol. 2020;72(2):288–306. doi: 10.1016/j.jhep.2019.09.026.
   PubMed Web of Science ®Google Scholar
• Baerlocher MO, Nikolic B, Sze DY. Adverse event classification: clarification and validation of the society of interventional radiology Specialty-Specific system. J Vasc Interv Radiol. 2023;34(1):1–3. doi: 10.1016/j.jvir.2022.10.011.
   PubMed Web of Science ®Google Scholar
• Di Costanzo GG, Tortora R, D’Adamo G, et al. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial. J Gastroenterol Hepatol. 2015;30(3):559–565. doi: 10.1111/jgh.12791.
   PubMed Web of Science ®Google Scholar
• Kim N, Cheng J, Jung I, et al. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. J Hepatol. 2020;73(1):121–129. doi: 10.1016/j.jhep.2020.03.005.
   PubMed Web of Science ®Google Scholar
• Tinguely P, Frehner L, Lachenmayer A, et al. Stereotactic image-guided microwave ablation for malignant liver tumors-a multivariable accuracy and efficacy analysis. Front Oncol. 2020;10:842. doi: 10.3389/fonc.2020.00842.
   PubMed Web of Science ®Google Scholar
• Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29(5):2698–2705. doi: 10.1007/s00330-018-5809-0.
   PubMed Web of Science ®Google Scholar
• Lachenmayer A, Tinguely P, Maurer MH, et al. Stereotactic image-guided microwave ablation of hepatocellular carcinoma using a computer-assisted navigation system. Liver Int. 2019;39(10):1975–1985. doi: 10.1111/liv.14187.
   PubMed Web of Science ®Google Scholar
• Tinguely P, Paolucci I, Ruiter SJS, et al. Stereotactic and robotic minimally invasive thermal ablation of malignant liver tumors: a systematic review and meta-analysis. Front Oncol. 2021;11:713685. doi: 10.3389/fonc.2021.713685.
   PubMed Web of Science ®Google Scholar
• van Erp GCM, Hendriks P, Broersen A, et al. Computational modeling of thermal ablation zones in the liver: a systematic review. Cancers (Basel). 2023;15(23):5684. doi: 10.3390/cancers15235684.
   PubMed Web of Science ®Google Scholar